Skip to main content
IQV logo

IQVIA Holdings Inc.

IQVNYSEHealthcareDiagnostics & Research

$278.32Today:- (-)1Y +26.56%

As of Oct 22, 2026 close

Market cap
$46.56B
P/E (TTM)
33.86
Forward P/E
30.99
Dividend yield
-
52-week range
$154.50$277.40
Volume (live)
-
Avg. volume (3M)
1.49M

IQVIA Holdings (IQV) Stock Price & Financial Analysis

IQVIA Holdings Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$273.80 - $282.98
52-Week High$277.40
52-Week Low$154.50
Open$274.99
Volume (last close)1.67M
Average Volume (3M)1.49M
Earnings & Profitability
Revenue (TTM)16.98B
Net Income (TTM)1.38B
Free Cash Flow (TTM)2.18B
EPS (TTM)$8.08
Profit Margin8.10%
Operating Margin14.06%
Return on Equity (ROE)22.28%
Debt to Equity2.63
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Size & Valuation
Market Cap46.56B
Shares Outstanding167.30M
P/E Ratio (TTM)33.86
Forward P/E30.99
Price to Sales (P/S)2.74
Price to Book (P/B)7.55
EV/EBITDA17.26
Technical Indicators
50-Day MA$261.08
200-Day MA$208.16
1-Year Change+26.56%

Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology

Compare IQV with other stocks

IQVIA Holdings at a Glance

As of the Oct 22, 2026 close, IQVIA Holdings (IQV) has a market capitalization of $46.56B. The stock trades at 33.9× trailing earnings, 31.0× forward earnings and 2.7× sales. Over the trailing twelve months it earned $1.38B on revenue of $16.98B (a 8.1% profit margin) and generated $2.18B of free cash flow. Revenue grew 8.2% year over year.

As of its latest reported balance sheet, it holds $1.91B in cash and securities against $16.24B of debt, a net debt position of $14.33B.

IQVIA Holdings does not currently pay a dividend.

The share price is up 26.6% over the past year. At $278.32 (the Oct 22, 2026 close) it sits near the top of its 52-week range of $154.50 to $277.40, above its 200-day moving average of $208.16.

Based on 17 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $298.64, 7.3% above the Oct 22, 2026 close.

Frequently Asked Questions About IQVIA Holdings

What is the current stock price for IQV?

As of the Oct 22, 2026 close, IQV stock trades at $278.32. The 52-week range is $154.50–$277.40, with a day range of $273.80–$282.98.

What is the P/E ratio for IQV?

As of the Oct 22, 2026 close, IQVIA Holdings's trailing twelve-month (TTM) P/E ratio is 33.9, meaning investors pay $33.9 for every $1 of annual earnings. The forward P/E is 31.0, reflecting analyst expectations for future earnings. IQVIA Holdings operates in the Healthcare sector.

Does IQV pay dividends?

IQVIA Holdings does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.

What do analysts recommend for IQV?

Based on ratings from 17 professional analysts over the last 90 days, the consensus for IQV is Buy. The average 12-month price target is $298.64, a 7.3% upside from the Oct 22, 2026 close of $278.32.

What is the market cap of IQV?

As of the Oct 22, 2026 close, IQVIA Holdings's market capitalization is $46.56B, classifying it as a large-cap company. IQVIA Holdings operates in the Healthcare sector within the Diagnostics & Research industry.